UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ambiguous Phenotypes and Genotypes in 16 Children With Acute Leukemia as Characterized by Multiparameter Analysis

Blood, 1988-06, Vol.71 (6), p.1518-1528

1988

Volltextzugriff (PDF)

Phenotypic and genotypic heterogeneity in infant acute leukemia. I: Acute lymphoblastic leukemia

Leukemia, 1989-06, Vol.3 (6), p.431-439

1989

Volltextzugriff (PDF)

Maligne Lymphome - Diagnostik und Stadieneinteilung

Deutsche medizinische Wochenschrift, 2008-03, Vol.115 (18), p.703-707

2008

Volltextzugriff (PDF)

Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor

Leukemia research, 1992, Vol.16 (3), p.287-298

1992

Volltextzugriff (PDF)

Immunosuppressive effects of recombinant interferon‐α during long‐term treatment of cancer patients

Cancer, 1989-05, Vol.63 (10), p.1990-1993

1989

Volltextzugriff (PDF)

Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia—Case report and review of the literature

Leukemia Research, 1986, Vol.10 (4), p.361-368

1986

Volltextzugriff (PDF)

Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples

Natural immunity, 1992-05, Vol.11 (3), p.117

1992

Volltextzugriff (PDF)

GM-CSF-mediated proliferation induction improves the susceptibility of leukemia cells to lymphokine-activated killer cells

International journal of hematology, 1992-06, Vol.55 (3), p.255-264

1992

Volltextzugriff (PDF)

Abnormalities of B cell Activation and Immunoregulation in Patients with Chronic Inflammatory Liver Diseases

Immunobiology (1979), 1988-12, Vol.178 (3), p.215-223

1988

Volltextzugriff (PDF)

Induction of lymphokine-activated killer cells against human leukemia cells in vitro

Blut, 1989-07, Vol.59 (1), p.21-24

1989

Volltextzugriff (PDF)

Lymphokine-activated killer (LAK) cells against human leukemia: augmentation of LAK-cell cytotoxicity by combinations of lymphokines or cytokines

Haematology and blood transfusion, 1990, Vol.33, p.103

1990

Volltextzugriff (PDF)

Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis

Blood, 1988-06, Vol.71 (6), p.1518-1528

1988

Volltextzugriff (PDF)

Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86

Recent results in cancer research, 1993, Vol.131, p.269

1993

Volltextzugriff (PDF)

Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia

Oncology research and treatment, 1990-06, Vol.13 (3), p.166-174

1990

Volltextzugriff (PDF)

Incidence and clinical implications of acute hybrid leukemia in childhood

Haematology and blood transfusion, 1990, Vol.33, p.516

1990

Volltextzugriff (PDF)

Oncological rehabilitation: evaluation of the efficiency of inpatient rehabilitation

Rehabilitation (Stuttgart), 2002-02, Vol.41 (1), p.53

Teichmann, J V

2002

Volltextzugriff (PDF)

Onkologische Rehabilitation:Evaluation der Effektivität stationärer onkologischer Rehabilitationsmaßnahmen

Rehabilitation (Stuttgart), 2002-02, Vol.41 (1), p.53-63

Teichmann, J. V.

2002

Volltextzugriff (PDF)

Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivo

Recent results in cancer research, 1993, Vol.131, p.223

1993

Volltextzugriff (PDF)

Rehabilitation von Patienten mit malignen Lymphomerkrankungen

Onkologie (Heidelberg, Germany), 2000-01, Vol.6 (1), p.52-60

2000

Volltextzugriff (PDF)

Malignant lymphoma--diagnosis and staging

Deutsche medizinische Wochenschrift, 1990-05, Vol.115 (18), p.703-707

1990

Volltextzugriff (PDF)

Modulation of immune functions by long-term treatment with recombinant interferon-α2 in a patient with hairy-cell leukemia

Journal of interferon research, 1988, Vol.8 (1), p.15-24

1988

Volltextzugriff (PDF)

Induction of lymphokine-activated killer (LAK) cells against human leukemia cells

Haematology and blood transfusion, 1989, Vol.32, p.449

1989

Volltextzugriff (PDF)

Clinicopathological features and prognostic implications of immunophenotypic subgroups in childhood ALL: experience of the BFM-ALL Study 83

Haematology and blood transfusion, 1989, Vol.32, p.51

1989

Volltextzugriff (PDF)

Therapy of malignant lymphoma

Deutsche medizinische Wochenschrift, 1990-05, Vol.115 (19), p.743-748

1990

Volltextzugriff (PDF)

Therapie der malignen Lymphome

Deutsche medizinische Wochenschrift, 1990, Vol.115 (19), p.743-748

1990

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ambiguous Phenotypes and Genotypes in 16 Children With Acute Leukemia as Characterized by Multiparameter Analysis

Phenotypic and genotypic heterogeneity in infant acute leukemia. I: Acute lymphoblastic leukemia

Maligne Lymphome - Diagnostik und Stadieneinteilung

Cytotoxicity of interleukin 2-induced lymphokine-activated killer (LAK) cells against human leukemia and augmentation of killing by interferons and tumor necrosis factor

Immunosuppressive effects of recombinant interferon‐α during long‐term treatment of cancer patients

Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia—Case report and review of the literature

Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples

GM-CSF-mediated proliferation induction improves the susceptibility of leukemia cells to lymphokine-activated killer cells

Abnormalities of B cell Activation and Immunoregulation in Patients with Chronic Inflammatory Liver Diseases

Induction of lymphokine-activated killer cells against human leukemia cells in vitro

Lymphokine-activated killer (LAK) cells against human leukemia: augmentation of LAK-cell cytotoxicity by combinations of lymphokines or cytokines

Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis

Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86

Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia

Incidence and clinical implications of acute hybrid leukemia in childhood

Oncological rehabilitation: evaluation of the efficiency of inpatient rehabilitation

Onkologische Rehabilitation:Evaluation der Effektivität stationärer onkologischer Rehabilitationsmaßnahmen

Susceptibility of human leukemia cells to allogeneic and autologous lymphokine-activated killer cells and its augmentation by exposure of leukemia target cells to cytotoxic drugs in vitro and in vivo

Rehabilitation von Patienten mit malignen Lymphomerkrankungen

Malignant lymphoma--diagnosis and staging

Modulation of immune functions by long-term treatment with recombinant interferon-α2 in a patient with hairy-cell leukemia

Induction of lymphokine-activated killer (LAK) cells against human leukemia cells

Clinicopathological features and prognostic implications of immunophenotypic subgroups in childhood ALL: experience of the BFM-ALL Study 83

Therapy of malignant lymphoma

Therapie der malignen Lymphome

Suchergebnisse filtern